ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Immune checkpoint inhibitors in prostate cancer: Current and future practice"
Episode Synopsis
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts consider the current role of immune checkpoint inhibitors in prostate cancer and possible future directions.
The experts
Prof. Karim Fizazi - Gustave Roussy, Villejuif, France
Dr Sandy Srinivas - Stanford University, Stanford, CA, USA
Prof. Johann de Bono - The Institute of Cancer Research, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck Sharp & Dohme Corp. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/icis-prostate-cancer/
Listen to leading experts consider the current role of immune checkpoint inhibitors in prostate cancer and possible future directions.
The experts
Prof. Karim Fizazi - Gustave Roussy, Villejuif, France
Dr Sandy Srinivas - Stanford University, Stanford, CA, USA
Prof. Johann de Bono - The Institute of Cancer Research, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck Sharp & Dohme Corp. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/icis-prostate-cancer/
In God we trust